Lung Cancer

Searching for Novel Agents to Augment Atezolizumab Approval in Small Cell Lung Cancer    OncLive Despite the integration of frontline immunotherapy into routine practice for patients with extensive-stage small cell lung cancer (SCLC), researchers are still ...

Potential Biomarkers May Identify Lung Cancer Type, Stage, Survival Likelihood    Specialty Pharmacy Times A novel potential biomarker test could identify patients who would benefit from more advanced lung cancer screening.

IoT with Cloud Based Lung Cancer Diagnosis Model Using Optimal Support Vector Machine    DocWire News In the last decade, exponential growth of Internet of Things (IoT) and cloud computing takes the healthcare services to the next level.

Frontline Lung Cancer Treatment: What's the Best Strategy?    www.oncnursingnews.com/ Immunotherapy has drastically changed the treatment landscape for non-small cell lung cancer, but how can practitioners decide who should get frontline ...

Breast cancer research could expand lung cancer therapies    MSUToday New research into a genetic mutation's role in breast cancer could open new treatment options for lung cancer, according to a MSU scientist.

Addition of Pembrolizumab Shows Benefit in Oligometastatic NSCLC    Cancer Therapy Advisor The addition of pembrolizumab after locally ablative therapy appeared to improve clinical outcomes for patients with oligometastatic non-small cell lung cancer.

The prognostic significance of SHP2 and its binding protein Hook1 in n | OTT    Dove Medical Press Lingjuan He,1 Yinyan Li,1 Xin Huang,1 Hongqiang Cheng,2 Yuehai Ke,2 Linrun Wang1 1Department of Pharmacy, The First Affiliated Hospital, College of ...